nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbachol—PLA2G4A—Enalapril—Lisinopril—dilated cardiomyopathy	0.0375	1	CbGdCrCtD
Carbachol—Choline—SLC22A5—dilated cardiomyopathy	0.0305	1	CrCbGaD
Carbachol—Ulcer—Spironolactone—dilated cardiomyopathy	0.0292	0.0749	CcSEcCtD
Carbachol—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.0272	0.0696	CcSEcCtD
Carbachol—Fluid overload—Lisinopril—dilated cardiomyopathy	0.0182	0.0465	CcSEcCtD
Carbachol—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.0181	0.0463	CcSEcCtD
Carbachol—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0116	0.0298	CcSEcCtD
Carbachol—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.0111	0.0284	CcSEcCtD
Carbachol—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.011	0.0281	CcSEcCtD
Carbachol—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.011	0.0281	CcSEcCtD
Carbachol—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00984	0.0252	CcSEcCtD
Carbachol—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00823	0.0211	CcSEcCtD
Carbachol—Sweating—Furosemide—dilated cardiomyopathy	0.00807	0.0207	CcSEcCtD
Carbachol—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0078	0.02	CcSEcCtD
Carbachol—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00738	0.0189	CcSEcCtD
Carbachol—Asthma—Lisinopril—dilated cardiomyopathy	0.00708	0.0181	CcSEcCtD
Carbachol—Sweating increased—Lisinopril—dilated cardiomyopathy	0.0069	0.0177	CcSEcCtD
Carbachol—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00675	0.0173	CcSEcCtD
Carbachol—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00675	0.0173	CcSEcCtD
Carbachol—Dizziness—Spironolactone—dilated cardiomyopathy	0.00652	0.0167	CcSEcCtD
Carbachol—Flatulence—Furosemide—dilated cardiomyopathy	0.00648	0.0166	CcSEcCtD
Carbachol—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00632	0.0162	CcSEcCtD
Carbachol—Vomiting—Spironolactone—dilated cardiomyopathy	0.00627	0.0161	CcSEcCtD
Carbachol—Rash—Spironolactone—dilated cardiomyopathy	0.00622	0.0159	CcSEcCtD
Carbachol—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00622	0.0159	CcSEcCtD
Carbachol—Headache—Spironolactone—dilated cardiomyopathy	0.00618	0.0158	CcSEcCtD
Carbachol—Sweating—Lisinopril—dilated cardiomyopathy	0.00605	0.0155	CcSEcCtD
Carbachol—Nausea—Spironolactone—dilated cardiomyopathy	0.00586	0.015	CcSEcCtD
Carbachol—Shock—Furosemide—dilated cardiomyopathy	0.00528	0.0135	CcSEcCtD
Carbachol—Flushing—Lisinopril—dilated cardiomyopathy	0.00526	0.0135	CcSEcCtD
Carbachol—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00519	0.0133	CcSEcCtD
Carbachol—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00506	0.013	CcSEcCtD
Carbachol—Hypotension—Furosemide—dilated cardiomyopathy	0.00502	0.0128	CcSEcCtD
Carbachol—Flatulence—Lisinopril—dilated cardiomyopathy	0.00486	0.0125	CcSEcCtD
Carbachol—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00474	0.0122	CcSEcCtD
Carbachol—Pain—Furosemide—dilated cardiomyopathy	0.00459	0.0118	CcSEcCtD
Carbachol—Syncope—Lisinopril—dilated cardiomyopathy	0.00443	0.0113	CcSEcCtD
Carbachol—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00434	0.0111	CcSEcCtD
Carbachol—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00424	0.0109	CcSEcCtD
Carbachol—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00424	0.0109	CcSEcCtD
Carbachol—Infection—Lisinopril—dilated cardiomyopathy	0.004	0.0103	CcSEcCtD
Carbachol—Shock—Lisinopril—dilated cardiomyopathy	0.00396	0.0102	CcSEcCtD
Carbachol—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00389	0.00997	CcSEcCtD
Carbachol—Hypotension—Lisinopril—dilated cardiomyopathy	0.00376	0.00964	CcSEcCtD
Carbachol—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00367	0.00941	CcSEcCtD
Carbachol—Dizziness—Furosemide—dilated cardiomyopathy	0.00355	0.00909	CcSEcCtD
Carbachol—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00355	0.00908	CcSEcCtD
Carbachol—Pain—Lisinopril—dilated cardiomyopathy	0.00344	0.00882	CcSEcCtD
Carbachol—Vomiting—Furosemide—dilated cardiomyopathy	0.00341	0.00874	CcSEcCtD
Carbachol—Rash—Furosemide—dilated cardiomyopathy	0.00338	0.00867	CcSEcCtD
Carbachol—Dermatitis—Furosemide—dilated cardiomyopathy	0.00338	0.00866	CcSEcCtD
Carbachol—Headache—Furosemide—dilated cardiomyopathy	0.00336	0.00861	CcSEcCtD
Carbachol—Nausea—Furosemide—dilated cardiomyopathy	0.00319	0.00817	CcSEcCtD
Carbachol—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00318	0.00816	CcSEcCtD
Carbachol—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00318	0.00816	CcSEcCtD
Carbachol—CHRM2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.00295	0.00544	CbGpPWpGaD
Carbachol—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—RAF1—dilated cardiomyopathy	0.00277	0.0051	CbGpPWpGaD
Carbachol—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00276	0.00706	CcSEcCtD
Carbachol—PLA2G4A—Endothelins—RAF1—dilated cardiomyopathy	0.00269	0.00497	CbGpPWpGaD
Carbachol—Dizziness—Lisinopril—dilated cardiomyopathy	0.00266	0.00682	CcSEcCtD
Carbachol—PLA2G4A—AGE/RAGE pathway—RAF1—dilated cardiomyopathy	0.0026	0.00479	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—TTN—dilated cardiomyopathy	0.00258	0.00476	CbGpPWpGaD
Carbachol—Vomiting—Lisinopril—dilated cardiomyopathy	0.00256	0.00656	CcSEcCtD
Carbachol—Rash—Lisinopril—dilated cardiomyopathy	0.00254	0.00651	CcSEcCtD
Carbachol—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00254	0.0065	CcSEcCtD
Carbachol—Headache—Lisinopril—dilated cardiomyopathy	0.00252	0.00646	CcSEcCtD
Carbachol—Nausea—Lisinopril—dilated cardiomyopathy	0.00239	0.00613	CcSEcCtD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—RAC1—dilated cardiomyopathy	0.00235	0.00434	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00234	0.00431	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00231	0.00427	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—ACTN2—dilated cardiomyopathy	0.00224	0.00413	CbGpPWpGaD
Carbachol—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00201	0.00371	CbGpPWpGaD
Carbachol—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00195	0.0036	CbGpPWpGaD
Carbachol—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00194	0.00359	CbGpPWpGaD
Carbachol—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00193	0.00355	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—VCL—dilated cardiomyopathy	0.0019	0.00351	CbGpPWpGaD
Carbachol—PLA2G4A—AGE/RAGE pathway—EGFR—dilated cardiomyopathy	0.00178	0.00329	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.00177	0.00327	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.00171	0.00315	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.00167	0.00309	CbGpPWpGaD
Carbachol—CHRM1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00161	0.00297	CbGpPWpGaD
Carbachol—CHRM3—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.0016	0.00296	CbGpPWpGaD
Carbachol—CHRM2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00159	0.00293	CbGpPWpGaD
Carbachol—PLA2G4A—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.00158	0.00292	CbGpPWpGaD
Carbachol—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00158	0.00292	CbGpPWpGaD
Carbachol—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00158	0.00291	CbGpPWpGaD
Carbachol—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00156	0.00288	CbGpPWpGaD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—RAF1—dilated cardiomyopathy	0.00156	0.00288	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00153	0.00283	CbGpPWpGaD
Carbachol—CHRNA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00151	0.00279	CbGpPWpGaD
Carbachol—PLA2G4A—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.00149	0.00275	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00149	0.00274	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00149	0.00274	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—ANKRD1—dilated cardiomyopathy	0.00147	0.00271	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0014	0.00258	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00139	0.00257	CbGpPWpGaD
Carbachol—CHRM1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00139	0.00256	CbGpPWpGaD
Carbachol—CHRM3—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00138	0.00256	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00138	0.00255	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—TAZ—dilated cardiomyopathy	0.00138	0.00255	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00138	0.00254	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00133	0.00245	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.0013	0.0024	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00129	0.00239	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00128	0.00237	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00126	0.00232	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00125	0.00231	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—SDHA—dilated cardiomyopathy	0.00125	0.0023	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00124	0.00229	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00124	0.00229	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00124	0.00229	CbGpPWpGaD
Carbachol—CHRM1—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00123	0.00226	CbGpPWpGaD
Carbachol—CHRM3—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00122	0.00226	CbGpPWpGaD
Carbachol—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00121	0.00224	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.0012	0.00221	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.0012	0.00221	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00119	0.0022	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00119	0.0022	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00118	0.00218	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00118	0.00218	CbGpPWpGaD
Carbachol—CHRNA2—Neuronal System—RAF1—dilated cardiomyopathy	0.00116	0.00214	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00111	0.00205	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.00111	0.00205	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00111	0.00205	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0011	0.00203	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00108	0.00199	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00107	0.00198	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00107	0.00198	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00107	0.00198	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00106	0.00196	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00106	0.00196	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00102	0.00188	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00102	0.00187	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00101	0.00186	CbGpPWpGaD
Carbachol—PLA2G4A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000987	0.00182	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000985	0.00182	CbGpPWpGaD
Carbachol—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000977	0.0018	CbGpPWpGaD
Carbachol—CHRM3—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000974	0.0018	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—ITGB1—dilated cardiomyopathy	0.000955	0.00176	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00092	0.0017	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000917	0.00169	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000911	0.00168	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000911	0.00168	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000908	0.00168	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000908	0.00168	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000908	0.00168	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000899	0.00166	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000899	0.00166	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ANKRD1—dilated cardiomyopathy	0.00088	0.00162	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000874	0.00161	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000873	0.00161	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000871	0.00161	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00087	0.00161	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000861	0.00159	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000847	0.00156	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000844	0.00156	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000836	0.00154	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—TAZ—dilated cardiomyopathy	0.000827	0.00153	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00082	0.00151	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000818	0.00151	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—CD36—dilated cardiomyopathy	0.000815	0.0015	CbGpPWpGaD
Carbachol—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000813	0.0015	CbGpPWpGaD
Carbachol—CHRM3—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000811	0.0015	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00081	0.00149	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000804	0.00148	CbGpPWpGaD
Carbachol—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000803	0.00148	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000778	0.00144	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000778	0.00144	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—RAC1—dilated cardiomyopathy	0.000768	0.00142	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000761	0.00141	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000761	0.0014	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—SDHA—dilated cardiomyopathy	0.000748	0.00138	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000742	0.00137	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000725	0.00134	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000723	0.00133	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.0007	0.00129	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.0007	0.00129	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000698	0.00129	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000691	0.00128	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000668	0.00123	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000665	0.00123	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000662	0.00122	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000656	0.00121	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000647	0.00119	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000645	0.00119	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000639	0.00118	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000607	0.00112	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000605	0.00112	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000598	0.0011	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000567	0.00105	CbGpPWpGaD
Carbachol—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000558	0.00103	CbGpPWpGaD
Carbachol—CHRM3—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000556	0.00103	CbGpPWpGaD
Carbachol—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000551	0.00102	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000518	0.000955	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000515	0.00095	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000515	0.00095	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000513	0.000947	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000513	0.000947	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—RAF1—dilated cardiomyopathy	0.000509	0.00094	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000508	0.000938	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000508	0.000938	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000506	0.000933	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000493	0.00091	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000491	0.000907	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000487	0.000898	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000479	0.000883	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000477	0.000881	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000472	0.000872	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000467	0.000863	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000467	0.000863	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000466	0.00086	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000466	0.00086	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000463	0.000856	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000462	0.000853	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000461	0.000852	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000461	0.000852	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000459	0.000848	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000459	0.000848	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000458	0.000845	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000441	0.000813	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000435	0.000802	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000433	0.0008	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000429	0.000792	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000427	0.000789	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000421	0.000777	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000421	0.000777	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00042	0.000774	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000416	0.000768	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000415	0.000767	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000415	0.000765	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000414	0.000764	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000396	0.000731	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000395	0.000728	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000391	0.000721	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000376	0.000693	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000374	0.000691	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000371	0.000684	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000359	0.000664	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000358	0.000661	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000355	0.000655	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000353	0.000652	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000341	0.00063	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00034	0.000628	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—GPX1—dilated cardiomyopathy	0.000339	0.000626	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000337	0.000621	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000335	0.000619	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—CD36—dilated cardiomyopathy	0.00033	0.00061	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000311	0.000574	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00031	0.000572	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000307	0.000567	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—AGT—dilated cardiomyopathy	0.000297	0.000549	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000292	0.000539	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000292	0.000538	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000291	0.000536	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000288	0.000532	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000288	0.000531	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000279	0.000514	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000278	0.000513	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000276	0.00051	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000276	0.00051	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000275	0.000508	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000275	0.000508	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000275	0.000508	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000273	0.000503	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000273	0.000503	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000265	0.000489	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000264	0.000487	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000261	0.000482	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00026	0.00048	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000257	0.000474	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000256	0.000472	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000253	0.000468	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000253	0.000467	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000252	0.000465	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00025	0.000461	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000249	0.000459	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000249	0.000459	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000248	0.000458	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000245	0.000453	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000212	0.000392	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000212	0.000391	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00021	0.000387	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	0.000203	0.000375	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000201	0.000372	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000201	0.000371	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.0002	0.00037	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000199	0.000367	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CD36—dilated cardiomyopathy	0.000198	0.000365	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—AGT—dilated cardiomyopathy	0.000178	0.000329	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000176	0.000324	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000175	0.000323	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000173	0.00032	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000173	0.00032	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000173	0.000319	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000173	0.000319	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000171	0.000315	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000156	0.000289	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000156	0.000288	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000154	0.000285	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000149	0.000276	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	0.000149	0.000275	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000148	0.000272	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.00012	0.000222	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.00012	0.000222	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000119	0.000219	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000118	0.000218	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000104	0.000191	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000103	0.000191	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000102	0.000189	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	7.11e-05	0.000131	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	7.09e-05	0.000131	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	7.02e-05	0.00013	CbGpPWpGaD
